
MIST Valuation
Milestone Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
MIST Relative Valuation
MIST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MIST is overvalued; if below, it's undervalued.
Historical Valuation
Milestone Pharmaceuticals Inc (MIST) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.14. The fair price of Milestone Pharmaceuticals Inc (MIST) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.57
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-17.34
P/B
Median3y
2.14
Median5y
2.12
-22.49
FCF Yield
Median3y
-35.02
Median5y
-28.48
Competitors Valuation Multiple
The average P/S ratio for MIST's competitors is 28.37, providing a benchmark for relative valuation. Milestone Pharmaceuticals Inc Corp (MIST) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

VRA
Vera Bradley Inc
2.210
USD
-7.92%

SOL
Emeren Group Ltd
1.930
USD
+0.52%

UPLD
Upland Software Inc
1.950
USD
-0.51%

ECOR
electroCore, Inc.
7.475
USD
+1.98%

SND
Smart Sand Inc
2.090
USD
+8.85%

BRAG
Bragg Gaming Group Inc
4.210
USD
-6.03%

FCAP
First Capital Inc
37.410
USD
-4.15%

ATOS
Atossa Therapeutics Inc
0.862
USD
-2.71%

PETS
Petmed Express Inc
3.980
USD
+5.85%

IGMS
IGM Biosciences Inc
1.280
USD
0.00%
FAQ

Is Milestone Pharmaceuticals Inc (MIST) currently overvalued or undervalued?
Milestone Pharmaceuticals Inc (MIST) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.14. The fair price of Milestone Pharmaceuticals Inc (MIST) is between to according to relative valuation methord.

What is Milestone Pharmaceuticals Inc (MIST) fair value?

How does MIST's valuation metrics compare to the industry average?

What is the current P/B ratio for Milestone Pharmaceuticals Inc (MIST) as of Jul 25 2025?

What is the current FCF Yield for Milestone Pharmaceuticals Inc (MIST) as of Jul 25 2025?

What is the current Forward P/E ratio for Milestone Pharmaceuticals Inc (MIST) as of Jul 25 2025?
